Merus N.V. (MRUS) vs Protagonist Therapeutics, Inc. (PTGX)
Detailed comparison between Merus N.V., Protagonist Therapeutics, Inc..Total Return (%)
Merus N.V. (MRUS)Protagonist Therapeutics, Inc. (PTGX)
Which stock do you think will perform better?
Merus N.V.
MRUS
Protagonist Therapeutics, Inc.
PTGX
| Metric | Merus N.V. (MRUS) | Protagonist Therapeutics, Inc. (PTGX) |
|---|---|---|
| Current Price | $63.26 | $55.48 |
| Change | 1.82 (2.96%) | -0.96 (-1.70%) |
| Market Cap | $4.71B | $3.44B |
| Trailing P/E | 0.00 | 71.13 |
| Forward P/E | -16.22 | -38.80 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $63.43 | $60.60 |
| 52-Week Low | $33.19 | $32.50 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-4.16 | $0.78 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| MRUS | 19.12% | 59.18% | 14.41% | 367.21% | 530.08% | 530.08% |
| PTGX | 4.01% | 45.62% | 56.06% | 231.42% | 374.19% | 374.19% |